Trial Profile
Phase I study of a novel schedule of capecitabine and docetaxel in patients with advanced solid tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 11 Aug 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 07 Aug 2006 Status change
- 28 Feb 2006 New trial record.